WANBURY
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Wanbury along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-3.19₹ -7.9
As on Oct 15, 2025, 4:01 PM IST
Wanbury Price Performance
Today's LowToday's High
₹240.00₹251.05
₹240.00
52 Weeks' Low52 Weeks' High
₹155.00₹330.00
₹240.00
Open Price
₹247.70
Prev. Close
₹247.90
Volume
7,007
Over the last 5 years, the share price of Wanbury has gained 48.09% CAGR. Over the past year, the corresponding return has been -1.72%.
Wanbury’s current P/E of 18.30x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Wanbury Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Wanbury | -3.32 | -6.32 | -11.44 | -6.23 | -1.72 | 52.33 | 48.09 |
| Sun Pharmaceutical Industries | 1.37 | 3.22 | -4.26 | -3.00 | -12.83 | 19.07 | 27.53 |
| Divi's Laboratories | 7.15 | 8.40 | -3.36 | 14.45 | 7.42 | 22.37 | 16.12 |
| Cipla | 4.23 | 0.65 | 4.49 | 5.16 | -0.86 | 12.03 | 15.18 |
| Torrent Pharmaceuticals | -1.04 | -0.06 | 2.63 | 9.45 | 0.93 | 30.71 | 21.02 |
| Dr. Reddy's Laboratories | -0.21 | -5.31 | -2.33 | 6.58 | -6.93 | 12.43 | 4.03 |
| Mankind Pharma | -0.41 | -5.55 | -8.00 | 0.50 | -11.13 | 19.66 | 11.37 |
| Zydus Lifesciences | -1.03 | -5.86 | 0.92 | 10.38 | -7.77 | 32.59 | 18.62 |
| Lupin | 2.05 | -4.99 | -0.34 | -3.34 | -13.56 | 41.21 | 14.15 |
| Alkem Laboratories | 1.96 | 1.82 | 13.51 | 13.71 | -10.53 | 21.47 | 16.08 |
| Aurobindo Pharma | 3.60 | 0.89 | -3.79 | -2.36 | -25.10 | 28.70 | 6.96 |
| Abbott India | -0.44 | -3.88 | -13.40 | -4.11 | 2.38 | 18.03 | 13.25 |
| Glenmark Pharmaceuticals | -1.95 | -10.05 | -15.22 | 37.27 | 4.62 | 68.54 | 31.81 |
| Biocon | 2.14 | -0.64 | -8.73 | 8.15 | 1.06 | 10.54 | -3.85 |
| Laurus Labs | 1.89 | -2.18 | 5.73 | 39.83 | 81.53 | 19.48 | 22.57 |
| GlaxoSmithKline Pharmaceuticals | 0.64 | -0.35 | -14.21 | -4.56 | 1.34 | 25.97 | 12.60 |
| Anthem Biosciences | 0.57 | -7.22 | 6.05 | 6.05 | 6.05 | 1.98 | 1.18 |
| Cohance Lifesciences | 1.02 | -11.65 | -17.60 | -26.56 | -28.08 | 30.24 | 20.24 |
| Ipca Laboratories | -4.03 | -0.80 | -11.60 | -4.72 | -23.64 | 13.32 | 4.56 |
| Gland Pharma | -1.05 | -3.97 | 2.07 | 35.67 | 17.31 | -3.51 | 1.23 |
Over the last one year, Wanbury has declined 1.72% compared to peers like Sun Pharmaceutical Industries (-12.83%), Divi's Laboratories (7.42%), Cipla (-0.86%). From a 5 year perspective, Wanbury has outperformed peers relative to Sun Pharmaceutical Industries (27.53%) and Divi's Laboratories (16.12%).
Wanbury Financials
Wanbury Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 251.71 | 250.22 |
| 10 | 252.27 | 251.39 |
| 20 | 252.25 | 254.01 |
| 50 | 263.11 | 260.11 |
| 100 | 271.38 | 262.02 |
| 200 | 255.47 | 253.74 |
Wanbury Share Holding Pattern
In the latest quarter, Wanbury saw a rise in promoter holding to 43.09%, while DII stake unchanged at 0.00%, FII holding fell to 0.82%, and public shareholding moved down to 56.08% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Wanbury Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 08, 2025, 6:20 AM IST | Wanbury - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 06, 2025, 6:02 AM IST | Wanbury - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Sep 20, 2025, 1:17 AM IST | Wanbury - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| Sep 19, 2025, 2:20 AM IST | Wanbury - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association |
| Sep 19, 2025, 2:15 AM IST | Wanbury - Shareholder Meeting / Postal Ballot-Outcome of AGM |
About Wanbury
Wanbury Ltd. is a Public Limited Listed company incorporated on 11/08/1988 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L51900MH1988PLC048455 and registration number is 048455. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 599.51 Cr. and Equity Capital is Rs. 32.77 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressBSEL Tech Park, B-Wing, 10th Floor, Sector 30-A, New Mumbai Maharashtra 400703
- Contact
Management
- Mr. K ChandranWhole Time Director
- Mr. Mohan Kumar RayanaWhole Time Director
- Ms. Anupama VaidyaInd. Non-Executive Woman Director
- Mr. Mridul Sumanlal MehtaInd. Non-Executive Director
- Mr. P V Sankar DassInd. Non-Executive Director
- Mr. Manojkumar K GursahaniInd. Non-Executive Director
FAQs on Wanbury Share Price
What is the share price of Wanbury?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Wanbury is ₹240.00 as on Oct 15, 2025.
What kind of stock is Wanbury?
The Wanbury is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Wanbury?
The market cap of Wanbury is ₹786.49 Cr as on Oct 15, 2025.
What are today's High and Low prices of Wanbury?
Today’s highest and lowest price of Wanbury are ₹251.05 and ₹240.00.
What are the 52 Week High and 52 Week Low of Wanbury?
The 52-week high/low is the highest and lowest price at which Wanbury stock has traded in the past 52-week or nearly a year. The 52-week high of Wanbury is ₹330.00 and 52-week low of Wanbury is ₹155.00 as on Oct 15, 2025.
How has the Wanbury performed historically in terms of returns?
The Wanbury has shown returns of -3.19% over the past day, -6.32% for the past month, -11.44% over 3 months, -1.72% over 1 year, 52.33% across 3 years, and 48.09% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Wanbury?
P/E ratio of and PB ratio of Wanbury are 18.30 and 20.29 on Oct 15, 2025. While the company gives a dividend yield of 0.00 per annum.
Trending In Market
Mutual Funds Screener
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Pulse